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This study was designed to assess the parameters influencing the magnitude and type of immune responses generated
to plasmids encoding the hemagglutinin/neuraminidase (HN) and fusion (F) proteins of bovine parainfluenzavirus type 3
(BPIV3). Mice immunized with plasmids expressing HN or F under control of the Rous sarcoma virus long terminal repeat
promoter were primed, but they did not develop measurable immune responses. In contrast, strong humoral and cellular
immune responses were induced with constructs containing the human cytomegalovirus immediate-early promoter and
intron A. After immunization with both HN- and F-encoding plasmids, enhanced responses were observed. Analysis of in vitro
protein synthesis confirmed that the presence of the intron is crucial for the expression of the BPIV3 HN gene. Plasmid
encoding HN induced significantly higher serum antibody titers by intradermal injection than by intramuscular delivery,
whereas antigen-specific T cell proliferation was stronger in intramuscularly injected mice. Both the isotype ratios and the
cytokine profiles indicated a Th1-type response after intramuscular immunization and a mixed to Th2-type response in
intradermally immunized mice. A plasmid encoding a truncated, secreted form of HN induced a Th2-type immune response,
regardless of the route of delivery. In cotton rats, HN- and F-encoding plasmids conferred protection from BPIV3 challenge.
© 1999 Academic Press
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lINTRODUCTION
Bovine parainfluenza virus type 3 (BPIV3), a member of
he family Paramyxoviridae, is closely related to human
arainfluenza virus-3 (HPIV3), which is one of the leading
auses of respiratory infections, resulting in broncheoli-
is and pneumonia in children under 2 years of age (Knott
t al., 1994). BPIV3 has been recovered from healthy
attle (Kahns, 1981), cattle with signs of respiratory dis-
ase (Bryson et al., 1978), and aborted fetuses (Dunne et
l., 1973). Severe respiratory disease involving BPIV3
sually occurs in conjunction with environmental stress
nd the presence of other etiological agents, such as
ovine herpesvirus-1 (BHV-1), bovine respiratory syncy-
ial virus (BRSV), bovine viral diarrhea virus (BVDV), Pas-
eurella haemolytica, or Haemophilus somnus (Martin et
l., 1986). Although a variety of combination vaccines are
vailable, this disease complex, also called “shipping
ever,” remains a major source of economic loss in the
attle industry. As a result of the ubiquitous nature of
PIV3 and frequent vaccination with multivalent vaccines
ontaining BPIV3 (Van Donkersgoed et al., 1991), it is
ifficult to study BPIV3 in cattle. Although it is possible to
se colostrum-deprived calves, these animals are usu-
1 Published as VIDO Journal Series No. 256.
2 To whom reprint requests should be addressed. Fax: (306) 966-1478. E-mail: vandenhurk@sask.usask.ca.
35lly very susceptible to other infections. For these rea-
ons, a challenge model for BPIV3 infection was devel-
ped in Sigmodon hispidus cotton rats (Breker-Klassen
t al., 1995).
The immunodominant proteins of BPIV3 are the hem-
gglutinin-neuraminidase (HN; 69 kDa) and the fusion (F;
7 kDa) proteins. Both glycoproteins are required for the
ormation of syncytia (Sakai and Shibuta, 1989) and affect
he pathogenicity of the virus. When delivered as a sub-
nit vaccine in an appropriate adjuvant or in recombinant
denovirus, HN and F can induce protection from BPIV3
hallenge (Breker-Klassen et al., 1995; Haanes et al.,
997).
DNA immunization has been shown to be one of the
ost simple and yet versatile methods of inducing both
umoral and cellular immune responses, as well as
rotection against a variety of infectious agents, includ-
ng viruses, bacteria, and parasites (reviewed in Don-
elly et al., 1994; Whalen et al., 1995; Hassett and Whit-
on, 1996). Different routes and methods have been used
o deliver plasmid DNA to tissues. Although intramuscu-
ar (IM) immunization has been used in the majority of
he studies, other means of administration are also ef-
ective, such as direct intradermal (ID) delivery, epider-
al delivery on gold particles, intravenous injection in
omplexes with cationic lipids, and administration in
iposomes (Tang and Johnston, 1992; Stribling et al.,
992; Eisenbraun et al., 1993; Fynan et al., 1993; Zhu et
0042-6822/99 $30.00
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36 VAN DRUNEN LITTEL-VAN DEN HURK ET AL.l., 1993). The magnitude and nature of the immune
esponses elicited to DNA vaccines may depend on the
oute and the method of delivery, as well as the type and
ellular localization of the expressed antigen (Pertmer et
l., 1996; Cardoso et al., 1996; Feltquate et al., 1997;
ewis et al., 1997; Braun et al., 1997). Although this
mplies that the responses induced by DNA immuniza-
ion need to be evaluated for each new antigen-encoding
onstruct, it also provides the unique opportunity to ma-
ipulate the system to obtain the desired responses.
This study was designed to analyze the potential of
sing HN and F encoding plasmids to induce immunity to
PIV3 and to assess the parameters influencing the
agnitude and type of immune responses generated. In
he present report, we demonstrate the induction of
trong cellular and humoral immune responses by im-
unization with plasmids expressing BPIV3 HN and F
rovided the vector contained an intron. Furthermore, the
ype of immune response elicited was dependent on the
oute of delivery, as well as the cellular localization of the
xpressed antigen. In cotton rats, HN- and F-expressing
lasmids induced protective immunity against challenge
ith BPIV3.
RESULTS
mmune responses to BPIV3 glycoproteins are
nhanced when expressed under control of the
CMV immediate-early promoter and intron A
In the constructs used for the first experiment, expres-
ion of HN and F was driven by the Rous sarcoma virus
RSV) long terminal repeat (LTR) promoter. C57BL/6 mice
ere immunized IM with 100 mg of pSLRSVHN, pSLRSVF,
r pSLRSV0 plasmid. However, even after the second
mmunization, no seroconversion was observed in any of
he animals (Fig. 1A). To determine whether priming had
ccurred, all mice, except half of the pSLRSV0-immu-
ized group, were immunized with 5 mg of live BPIV3 at
1 weeks after the secondary immunization. When the
ntibody responses were analyzed, an anamnestic re-
ponse was observed in the mice immunized with
SLRSVHN or pSLRSVF compared with the mice that
eceived pSLRSV0 (Fig. 1A). The pSLRSVHN-immunized
ice also had stronger proliferative responses than the
SLRSV0-injected animals, but the difference between
he mice immunized with pSLRSVF or pSLRSV0 was not
ignificant (Fig. 1B). Cytokine ELISPOT assays demon-
trated a predominance of interferon (IFN)g-secreting
ells over interleukin (IL)-4-secreting cells in the mice
mmunized with pSLRSVHN, pSLRSVF, or pSLRSV0 and
PIV3 (Fig. 1C), which is suggestive of a Th1-type re-
ponse. This was confirmed by a comparison of the
sotypes of the antibody responses, which showed a
atio of IgG2a . IgG1 for these groups of mice (Fig. 1D).
Because of the lack of response to the pSLRSV plas-
ids, both HN and F genes were expressed under con- erol of the HCMV immediate-early (IE) promoter and in-
ron A (IA). C57BL/6 mice were immunized twice with 50
g IM and 10 mg ID of pSLIAHN, pSLIAF, pSLIAHN and
SLIAF, or pSLIA0. Four additional groups received 50
g IM and 10 mg ID of pSLRSVHN, pSLRSVF, pSLRSVHN
nd pSLRSVF, or pSLRSV0. Again, none of the mice
njected with the pSLRSV constructs developed an anti-
ody response. Furthermore, splenocytes isolated 2
eeks after the second immunization were not activated
data not shown). In contrast, all mice immunized with
SLIAHN or pSLIAF individually, or combined, serocon-
erted after one immunization, with an increase in anti-
ody titers after the second immunization (Fig. 2A). Co-
dministration of pSLIAHN and pSLIAF did not have a
ignificant effect on the total serum antibody titers, but
nhanced virus neutralization was observed in animals
mmunized with both plasmids (Fig. 2B). The presence of
ntigen-specific T cells in the vaccinated mice was de-
ermined by proliferation assays using splenocytes iso-
ated 2 weeks after the last immunization. As shown in
ig. 2C, the mice immunized with pSLIAHN or pSLIAF, or
combination of both, developed significantly higher
roliferative responses than the pSLIA0-immunized
ice. Furthermore, coadministration of pSLIAHN and
SLIAF resulted in significantly stronger proliferative re-
ponses than immunization with the individual plasmids.
o determine the type of immune response induced by
he HN- and F-expressing plasmids, cytokine patterns
ere determined. T cells isolated from mice immunized
ith pSLIAHN or pSLIAHN and pSLIAF secreted primar-
ly IFNg (Fig. 2D). Although very few cytokine-secreting
ells were found in splenocytes from the pSLIAF-immu-
ized mice, the predominant cytokine was also IFNg (Fig.
D). These data indicate that strong, primarily Th1-type,
mmune responses are induced after injection of mice
ith the pSLIA constructs. Furthermore, mice immunized
ith both HN- and F-expressing plasmids not only
howed higher levels of neutralizing antibody and T cell
roliferation but also had significantly more IFNg- and
L-4-secreting cells than the mice immunized with the
ndividual plasmids.
resence of IA enhances in vitro expression
f BPIV3 HN
The major difference between the pSLRSV and pSLIA
onstructs is the presence of the IA in the pSLIA vector.
o determine whether this is a crucial element for the
xpression of BPIV3 proteins, the IA was removed from
SLIAHN, and in vitro expression levels were determined
fter transfection of COS-7 cells. Figure 3 demonstrates
hat although HN protein was clearly visible when IA is
resent (lane 3), barely detectable levels were produced
ithout the IA (lane 4). To assess whether this might be
pplicable to additional antigens, the effect of the pres-
nce of IA on expression levels of glycoprotein D (gD) of
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37DNA IMMUNIZATION WITH BPIV3 GENESHV-1 and outer membrane lipoprotein of Actinobacillus
leuropneumoniae (OmlA) was determined. The pres-
nce of IA strongly influenced the expression of the
acterial antigen OmlA (lanes 5 and 6), which was virtu-
lly nonexistent in cells transfected with the plasmid
ithout intron. In contrast, the presence of IA had no
ffect on production of the gD protein of BHV-1 (lanes 1
nd 2). Because the effect of an intron on protein expres-
ion has been suggested to occur at the level of mRNA
ransport, not transcription, RT-PCR on whole-cell RNA
xtracts was carried out using gene-specific primers. All
lasmids were found to transcribe the genes regardless
f the presence or absence of the intron (data not
hown). These data suggest that as previously found
FIG. 1. Immune responses in mice immunized with pSLRSV construct
wice IM with 100 mg of pSLRSVHN (
   
   
   ), pSLRSVF ( ), or pSLRSV0 (
 
a
SLRSVHN or pSLRSVF and half of the mice immunized with pSLRSV0
eceive the virus (f). (1) Groups administered virus. (A) ELISA titers w
ilution resulting in a reading of two standard deviations above the co
ymphocyte proliferation of splenocytes was measured 1 week after im
nd are expressed as mean SI 6 SEM for individual mice. (C) The freq
fter immunization with BPIV3. The results represent the average of t
ells/106 cells 6 SEM for individual mice. (D) Serum IgG subclass lev
LISAs were carried out on pooled sera and reported as the optical dHuang and Gorman, 1990), the effect of the intron is on rhe transfer of the message from the nucleus to the
ytoplasm.
oute of delivery influences the magnitude and type
f immune response to BPIV3 HN
Although some reports in the literature indicate that
he route of delivery influences the type of immune re-
ponse (Pertmer et al., 1995), others suggest that the
ethod, and not the route, has an impact (Feltquate et
l., 1997). To determine whether the route of delivery
ffects the type and/or magnitude of the immune re-
ponse generated to plasmid expressing HN of BPIV3,
57BL/6 mice were immunized IM or ID with different,
artially overlapping, doses of pSLIAHN. Control mice
ssing BPIV3 HN or F. C57BL/6 mice (eight per group) were immunized
Eleven weeks after the second immunization, all mice immunized with
ed 5 mg of live BPIV3 (
 
), whereas the other half of this group did not
sessed against BPIV3 and expressed as the reciprocal of the highest
lue. The results represent the mean titer 6 SEM. (B) Antigen-specific
tion with BPIV3. The results represent the average of triplicate wells
f IFNg- and IL-4-secreting cells in splenocytes was measured 1 week
wells and are expressed as the mean values of cytokine-secreting
e determined 1 week after immunization with BPIV3. Antigen-specific
at 405/490 nm at a serum dilution of 1:640.s expre
nd f).
receiv
ere as
ntrol va
muniza
uency o
riplicate
els wereceived pSLIA0. After one immunization, total HN-spe-
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38 VAN DRUNEN LITTEL-VAN DEN HURK ET AL.ific serum antibody levels were elevated in all groups in
dose-dependent manner. The titers continued to in-
rease with each subsequent immunization (Fig. 4A).
verall, ID immunization induced higher levels of HN-
pecific antibodies, with the 20 mg ID dose inducing
wofold to fivefold higher antibody titers than the 20 mg
M dose. After single (Fig. 4B), as well as multiple (data
ot shown), immunizations, the predominant isotype in
he IM immunized mice was IgG2a, whereas ID immu-
ized mice showed a mixed to predominantly IgG1-type
ntibody response. One week after the last immuniza-
ion, all mice were euthanized and cellular responses
ere measured. Figure 4C demonstrates that in contrast
o the serum antibody levels, superior levels of antigen-
pecific T cell proliferation were induced after IM injec-
FIG. 2. Immune responses in mice immunized with pSLIA constructs e
ith 50 mg IM and 10 mg ID of pSLIAHN (
   
   
   ), pSLIAF ( ), pSLIAHN 1 p
xpressed as the reciprocal of the highest dilution resulting in a readi
he mean titer 6 SEM. (B) Neutralizing antibody titers are expressed as a
EM. (C) Antigen-specific lymphocyte proliferation of splenocytes was
verage of triplicate wells and are expressed as mean SI 6 SEM for indi
as measured 2 weeks after the second immunization. The results rep
f cytokine-secreting cells/106 cells 6 SEM for individual mice.ion, regardless of the dose used. This difference in T cell ictivation appeared mainly to correlate to a greater num-
er of IFNg-secreting cells in the IM-immunized mice
Fig. 4D). In these mice, the ratio of IFNg-secreting cells
o IL-4-secreting cells in the ELISPOT was much greater
han 1, which is indicative of a Th1-type response,
hereas the IFNg/IL-4 ratio in the ID immunized mice
ppeared essentially balanced, with the difference be-
ween the numbers of IFNg- and IL-4-secreting cells
eing insignificant.
ellular localization determines the type of immune
esponse to BPIV3 HN
Previously, we demonstrated that the cellular localiza-
ion may influence both the magnitude and the type of
ing BPIV3 HN or F. C57BL/6 mice (six per group) were immunized twice
( ), or pSLIA0 (f). (A) ELISA titers were assessed against BPIV3 and
o standard deviations above the control value. The results represent
ndpoint using 100 PFU of BPIV3. The results represent the mean titer 6
red 2 weeks after the second immunization. The results represent the
ice. (D) The frequency of IFNg- and IL-4-secreting cells in splenocytes
the average of triplicate wells and are expressed as the mean valuesxpress
SLIAF
 ng of tw50% e
measu
vidual m
resentmmune response induced to glycoprotein D of BHV-1
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39DNA IMMUNIZATION WITH BPIV3 GENESBraun et al., 1997; van Drunen Littel-van den Hurk et al.,
998). To assess whether this observation also applies to
N of BPIV3, a gene encoding a truncated form of HN
as inserted into the pSLIATPs vector to create pSLIA-
HN. C57BL/6 mice were injected either with 100 mg IM
r 10 mg ID of pSLIAHN or pSLIAtHN. In contrast to
SLIAHN, which induced either a predominance of IgG2a,
hen administered IM, or a relatively balanced re-
ponse, when administered ID, pSLIAtHN elicited pri-
arily IgG1-type antibodies, regardless of the route of
elivery (Fig. 5).
accination of cotton rats with plasmids expressing
PIV3 HN or F
The cotton rat model established by Breker-Klassen et
l. (1995) was used to determine the ability of HN- and
-expressing plasmids to induce protection from BPIV3
hallenge. Mice developed generally enhanced immune
esponses when immunized with a mixture of HN- and
-expressing plasmids; thus cotton rats were immunized
ith both pSLIAHN and pSLIAF. Furthermore, IM and ID
outes of delivery appeared to bias the immune response
o be, respectively, more cellular or more humoral. As an
pproach to induce the broadest immune response and
est possible protection, the cotton rats received 80 mg
M divided over two quadriceps and 20 mg ID in the back
f both HN- and F-expressing plasmids. Control animals
ere given equivalent amounts of pSLIA0 plasmid. Three
eeks later, they received a second immunization, and
hey were challenged intranasally (IN) with BPIV3 3
eeks after the second immunization. All of the cotton
ats immunized with HN- and F-expressing plasmids
eveloped BPIV3-specific antibody titers prechallenge
FIG. 3. Transient expression of BHV-1 gD (lanes 1 and 2), BPIV3 HN
lanes 3 and 4), and A. pleuropneumoniae OmlA (lanes 5 and 6). COS-7
ells were transfected with pSLIAgD (lanes 1 and 2), pSLIAHN (lanes 3
nd 4), or pSLIAOm (lanes 5 and 6) with (lanes 1, 3, and 5) or without
lanes 2, 4, and 6) intron A. Cells were collected 52 h posttransfection,
nd radiolabeled proteins were concentrated by immunoprecipitation
ith the appropriate antibodies specific for BHV-1 gD, BPIV3 HN, or A.
leuropneumoniae OmlA. The proteins were separated by SDS–PAGE
n 8.5% reducing gels and visualized by autoradiography. The positions
f gD, HN, and OmlA are shown. Molecular weight markers 31023 are
ndicated in the right margin.Fig. 6A). Six days after challenge, an anamnestic re- mponse was detected in the group vaccinated with
SLIAHN and pSLIAF, whereas the animals in the
SLIA0 group did not develop any antibody response at
his time (Fig. 6A). Significant numbers of IgG- and IgA-
ecreting B cells were detected in the spleens of the
roup vaccinated with pSLIAHN and pSLIAF, whereas
ow numbers of IgA-secreting cells were detected in the
SLIA0-vaccinated group (Fig. 6B). Antigen-specific IgG
as detected in the trachea and lungs of the group
accinated with the HN- and F-encoding plasmids 2 days
fter challenge (Fig. 6C), and both IgA and IgG were
ound 6 days after challenge. No BPIV3-specific antibod-
es were found in tissues from the control animals. Two
ays after challenge, all animals in the control group
hed significant amounts of virus in the trachea and the
ungs, whereas only one animal in the vaccine group
hed a small amount of virus (Fig. 6D), suggesting that
accination of cotton rats with a BPIV3 DNA vaccine
rovides protection.
DISCUSSION
The purpose of the present study was to examine the
onditions required for plasmids encoding HN or F to
nduce protective immunity against BPIV3. Previously, we
emonstrated that a plasmid expressing BHV-1 gD under
ontrol of the RSV LTR promoter induced both humoral
nd cellular immune responses in mice (Lewis et al.,
997; Braun et al., 1997). Replacing the RSV LTR promoter
nd SV40 polyadenylation signal with the HCMV IE/IA
romoter and bovine growth hormone polyadenylation
ignal did not result in significantly enhanced gD-spe-
ific immune responses (Braun et al., 1997). In contrast,
lasmids expressing HN or F under control of RSV LTR
nly resulted in priming, whereas strong immune re-
ponses were induced with the HCMV IE/IA constructs
xpressing HN or F. A comparison of in vitro expression
evels in the presence and absence of the IA of HCMV
onfirmed that the intron is crucial for expression of HN
nd A. pleuropneumoniae OmlA but not for BHV-1 gD.
his is in agreement with a previous report on the en-
ephalomyocarditis virus VP1 gene, which was ex-
ressed at higher levels in the presence of the adenovi-
us tripartite leader sequences and an intron (Lee et al.,
997). Because all plasmids were observed to transcribe
he genes, the effect of the IA appears to occur at the
evel of mRNA transport. During a normal virus infection,
he mRNA of an RNA virus is made in the cytoplasm of
nfected cells. In contrast, after transfection of cells in
itro or after DNA immunization in vivo, transcription of
hese genes occurs in the nucleus. The HCMV 59 IA may
unction by overriding inappropriate signals or contribut-
ng essential signals lacking in the mRNA. Because bac-
erial mRNA is not normally synthesized inside the nu-
leus of a mammalian cell either, the same explanation
ay apply to OmlA.
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40 VAN DRUNEN LITTEL-VAN DEN HURK ET AL.The effect of route of delivery has been studied in a
umber of different systems. Muscle inoculation of a
lasmid encoding influenza nucleoprotein (NP) results in
redominantly IgG2a, or Th1-type, responses, whereas ID
r epidermal gene gun immunization yielded primarily
gG1, or Th2-type, immunity (Pertmer et al., 1996). In this
tudy, a 100-mg dose was used for IM injection and a
-mg dose was used for gene gun-mediated delivery, so
t is possible that the large amount of DNA in the extra-
ellular spaces after IM delivery has up-regulated and
riven the immune response to a Th-1 bias due to the
resence of immunostimulatory CpG motifs (Krieg et al.,
995).In contrast, gene gun-mediated immunization with
vector encoding hepatitis B virus (HBV) surface antigen
FIG. 4. Comparison of IM and ID delivery of plasmid expressing BPIV
0 mg (f), 40 mg (), or 20 mg (F) of pSLIAHN or ID with 20 mg (M), 10
g of pSLIA0 (l) or ID with 20 mg of pSLIA0 (L). ELISA titers were as
esulting in a reading of two standard deviations above the control valu
ubclass levels were determined 3 weeks after primary immunization.
t a serum dilution of 1:640. (C) Antigen-specific lymphocyte proliferation
epresent the average of triplicate wells and are expressed as mean SI
n splenocytes was measured 1 week after the last immunization. The re
alues of cytokine-secreting cells/106 cells 6 SEM for individual micelicited mixed responses that showed no Th1 or Th2 dias, and Plasmodium berghei CS antigen encoding
lasmid elicited both IgG1 and IgG2a responses after IM
njection, but only IgG1 after gene gun immunization
Pertmer et al., 1996). A more recent study demonstrated
hat the same dose of influenza hemagglutinin (HA) en-
oding plasmid elicits a primarily Th1-type response
fter IM or ID injection in saline but a Th2-type response
ith the gene gun, regardless of the route, which sug-
ests that the bias of the immune response is dependent
n the method, rather than the route of inoculation (Felt-
uate et al., 1997).Our studies on BHV-1 gD showed a
h1-type response after IM immunization, whereas ID
njection of BHV-1 gD resulted in a pronounced Th2 bias
Lewis et al., 1997; Braun et al., 1997). As we used higher
) C57BL/6 mice (eight per group) were immunized three times IM with
), or 5 mg (E) of pSLIAHN. Control groups were immunized IM with 80
against BPIV3 and expressed as the reciprocal of the highest dilution
results represent the mean titer 6 SEM. (B) BPIV3-specific serum IgG
ults represent the mean 6 SEM of the optical densities (405/490 nm)
nocytes was measured 1 week after the last immunization. The results
for individual mice. (D) The frequency of IFNg- and IL-4-secreting cells
present the average of triplicate wells and are expressed as the mean3 HN. (A
mg (
sessed
e. The
The res
of sple
6 SEM
sults reoses of plasmid for IM than for ID injection, again,
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41DNA IMMUNIZATION WITH BPIV3 GENESmmunostimulatory effects of CpG motifs could have
layed a role. However, the dose-response analyses of
N-encoding plasmid suggests that the DNA dose does
ot influence the type of response. Even when we used
he same amount of plasmid, significantly higher BPIV3-
pecific serum antibody titers were induced by ID immu-
ization than by IM delivery. In contrast, antigen-specific
cell proliferation was stronger in the IM injected mice.
oth the isotype ratios and the cytokine profiles indi-
ated a Th1-type response after IM immunization. In the
D immunized mice, a mixed response was observed,
ith a slight Th2 bias based on isotype ratios. According
o Bretscher et al. (1992), immunization with low doses of
ntigen leads to a primarily cellular response, whereas
igher doses induce predominantly humoral responses.
ecause the transfection efficiency is likely to be higher
y gene gun-mediated delivery than by injection with a
eedle, the amount of antigen produced in vivo may
ccount for the different types of responses reported by
eltquate et al. (1997). This same explanation may apply
o the differences in immune response observed after IM
nd ID immunization with the HN-encoding plasmid.
The observation that the route and method of delivery
f the plasmid are important determinants may be re-
ated not only to the level of antigen expression in vivo
ut also to the level and type of immune surveillance in
ifferent tissues. Evidence suggests that dendritic cells
re responsible for antigen presentation and initiation of
he immune response (Condon et al., 1996, Casares et
l., 1997). Because there is an abundance of dendritic
ells in the skin but not in the muscle, initiation of the
mmune response by antigen uptake and presentation by
endritic cells may be much more efficient in the skin
han in the muscle. Second, it appears that dendritic
ells not only present exogenous antigen to T cells but
re also transfected with injected plasmid DNA (Condon
FIG. 5. Immune responses in mice immunized with pSLIAHN or
SLIAtHN. C57BL/6 mice (six per group) were immunized IM with 100
g of pSLIAHN or pSLIAtHN or ID with 10 mg of pSLIAHN or pSLIAtHN.
PIV3-specific serum IgG subclass levels were determined 3 weeks
fter primary immunization. The results represent the mean 6 SEM of
he optical densities (405/490 nm) at a serum dilution of 1:640.t al., 1996; Casares et al., 1997). In the muscle, lower 1umbers of antigen presenting cells (APCs) may become
ransfected than in the skin, which may have a pro-
ounced impact on the magnitude of the response, if
ransfection of APCs is indeed crucial for the immune
esponse to occur. Furthermore, the APCs present in
ifferent tissues appear to have different characteristics
Everson et al., 1998), so different types of APCs may take
p the antigen and/or become transfected in the muscle
nd the skin, which may influence the types of responses
nduced. Finally, immune responses may be induced in
ifferent lymphoid compartments. It appears that after IM
mmunization, responses may be initiated in the spleen
Robinson and Torres, 1997), but after gene gun bom-
ardment, initiation of the immune response may occur
n the local draining lymph nodes (Boyle et al., 1996).
Although the types of responses generated by plasmid
njection have been analyzed for relatively few antigens,
vidence thus far suggests that the characteristics of the
ntigen are important determinants for the responses
enerated. Furthermore, the cellular localization of the
lasmid encoded antigen may dictate the magnitude
nd/or type of response. After IM immunization of mice
ith plasmids encoding membrane anchored or se-
reted versions of rabiesvirus G protein, measles virus
A, HBV surface antigen, or BHV-1 gD, similar levels of
ntibody were induced (Xiang et al., 1995; Cardoso et al.,
996; Chow et al., 1997; Lewis et al., 1997). However, the
embrane anchored forms of measles HA and BHV-1 gD
nduced a Th1-type response, whereas the secreted
orms elicited a Th2-biased response (Cardoso et al.,
996; Lewis et al., 1997). After ID injection, the response
as essentially Th2, regardless of the cellular localiza-
ion of gD, but the response to the secreted form was 1
rder of magnitude higher (Braun et al., 1997; van Drunen
ittel-van den Hurk et al., 1998).The secreted form of HN
ehaved very much like secreted forms of BHV-1 gD and
easles HA in that it induced predominantly IgG1, or a
h2-type, response, regardless of the route used. These
ata suggest that plasmids encoding secreted antigens
onsistently induce a strongly Th2-biased immune re-
ponse. In contrast to membrane-bound antigens, which
robably are presented mainly by transfected APCs, se-
reted antigens may be presented by transfected APCs,
s well as APCs that have taken up the secreted protein
rom extracellular spaces (Constant et al., 1995). Use of
he exogenous pathway of antigen presentation would
ctivate Th2-type cells, which would be consistent with
he bias of the immune response. This may enhance the
ntigen load and expand the repertoire of APCs (i.e., with
ntigen-specific B cells), which may increase the mag-
itude of the response.
In mice, the BPIV3 F protein induced lower cellular and
umoral immune responses than the HN protein. This is
n agreement with results reported by others for BPIV3
Breker-Klassen et al., 1995) and HPIV3 (Spriggs et al.,
987; Hall et al., 1991) and suggests that the F protein is
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42 VAN DRUNEN LITTEL-VAN DEN HURK ET AL.ess immunogenic. However, when mice were immu-
ized with both HN- and F-encoding plasmids, enhanced
mmune responses were observed. Thus to induce a
trong and broad immune response, the cotton rats were
mmunized with both HN- and F-expressing plasmids. All
otton rats vaccinated with pSLIAHN and pSLIAF were
rotected from BPIV3 challenge, as shown by a signifi-
ant reduction in virus replication in the trachea and
ungs compared with the pSLIA0 group. In contrast to the
ontrol animals, the cotton rats that received HN- and
-encoding plasmids contained significant numbers of
oth IgG- and IgA-secreting B cells in the spleen, as well
s IgA and IgG in the trachea and lungs, suggesting the
resence of BPIV3-specific systemic, as well as muco-
FIG. 6. Protection of cotton rats by vaccination with HN- and F-expre
D (20 mg) with pSLIAHN 1 pSLIAF or pSLIA0. (A) Serum ELISA tit
ostchallenge and expressed as the reciprocal of the highest dilution r
esults represent the mean titer 6 SEM. (B) Frequency of antigen-spec
nd 6 (d6) days after BPIV3 challenge. The number of antigen-specific I
or individual cotton rats. ND indicates not done. (C) Antigen-specific
hallenge. ELISA titers were expressed as the reciprocal of the highes
alue. The results represent the mean titer 6 SEM. (D) Virus isolation fr
solated is calculated as average PFU/g tissue 6 SEM.al, immunity. This is somewhat surprising, after sys- Femic immunization, but may be due to trafficking of
PCs to lymph nodes draining mucosal sites.
The data described here demonstrate the ability of
lasmids encoding BPIV3 HN or F to induce strong
umoral and cellular immune responses. By choosing
ifferent routes of immunization and/or cellular localiza-
ion of the expressed antigen, it is possible to induce a
alanced immune response, or a Th1- or Th2-biased
esponse. We demonstrated significant protection of cot-
on rats from BPIV3 by a combined IM and ID immuni-
ation regimen, using plasmids expressing HN and F.
ltimately, the versatility of this technology may be used
o select a vaccination regime that is optimal for induc-
ion of immunity and protection from BPIV3 by HN- and/or
lasmids. Cotton rats (six per group) were immunized IM (100 mg) and
re assessed against BPIV3 7 days prechallenge and 2 and 6 days
g in a reading of two standard deviations above the control value. The
- and IgA-secreting cells was measured in splenocytes isolated 2 (d2)
gA committed cells/106 splenocytes is calculated as the mean 6 SEM
d IgA levels in trachea and lungs 2 (d2) and 6 (d6) days after BPIV3
n resulting in a reading of two standard deviations above the control
hea and lungs 2 days after challenge with BPIV3. The amount of virusssing p
ers we
esultin
ific IgG
gG or I
IgG an
t dilutio
om trac-expressing plasmids.
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43DNA IMMUNIZATION WITH BPIV3 GENESMATERIALS AND METHODS
nimals
Six- to 8-week-old C57BL/6 mice were purchased from
harles River (Kingston, Ontario, Canada). Three- to
-month-old inbred cotton rats (S. hispidus) were
btained from a barrier-maintained colony at the Vet-
rinary Infectious Disease Organization (University of
askatchewan, Saskatoon, SK). Animals were handled
ccording to the guidelines of the Canadian Council of
nimal Care and the University of Saskatchewan Com-
ittee on Animal Care and Supply.
ells and virus
BPIV3 strain Sf4 was obtained from the American Type
ulture Collection (Rockville, MD). Virus was prepared in
ero cells with serum-free Eagle’s MEM containing 10%
BS (GIBCO BRL, Toronto, Ontario, Canada) as the
rowth medium. Virus titers of 1 3 108 to 5 3 108 were
outinely obtained.
lasmids
Plasmids pSLRSVHN and pSLRSVF were constructed
y cloning the genes coding for HN and F into pSL301
InVitrogen, Carlsbad, CA) under control of the promoter
rom the RSV LTR and with an SV40 polyadenylation
ignal (Lewis et al., 1997). To create the pSLIA vector, the
CMV IE gene promoter with the first IA and a bovine
rowth hormone terminator for transcription termination
nd polyadenylation was removed from the VCL1010
ector (Vical Inc., San Diego, CA) and inserted into
SL301 (Braun et al., 1997). The genes encoding HN and
were inserted into pSLIA, which generated plasmids
SLIAHN and pSLIAF. Plasmids expressing BHV-1 gD
Tikoo et al., 1990) and OmlA (Gerlach et al., 1993) were
reated by inserting the genes encoding these proteins
nto pSLIA, creating pSLIAgD and pSLIAOm, respectively.
ontrol plasmids were pSLRSV0 and pSLIA0, which con-
isted of the respective vectors with eukaryotic control
lements. To remove the intron, the original plasmids
ere first digested with SpeI and PstI. The SpeI site is
ithin the promoter, and the PstI site occurs just at the 39
oundary of the intron. This digestion removes part of the
romoter and the entire intron. The excised fragment
as replaced with a PCR product generated by amplifi-
ation of sequences 59 to the SpeI site (59-GACCGCCAT-
TTGACATTG-39) and a primer to the 59 boundary of the
ntron (59-TACTGCAGTCACTCTTGGCACG-39). The primer
orresponding to the 59 boundary of the intron contained
PstI site such that digestion of this fragment with SpeI
nd PstI produced a fragment that can be ligated into the
riginal cut plasmids and generate a plasmid identical to
he original except for the absence of the intron.
To create vectors that would secrete expressed pro-eins the signal sequences from BHV-1 gD (Tikoo et al., I990) and tissue plasminogen activator (TPA) were li-
ated into the pSLIA vector to create pSLIAgDs and
SLIATPs, respectively. Fragments were inserted into an
heI site directly after the signal sequences and a
amHI site slightly further downstream. To create the
runcated HN gene, a PCR was carried out with primers
pecific for sequences directly after the transmembrane/
ignal sequence of HN at approximately 240 bases from
he start and sequences at the 39 end of the gene. The 59
rimer (GCTAGCAAAATTCAAAAGACCTCAGATGAC) in-
orporated an NheI site, and the 39 primer (GGATC-
AGTTTAGCTGCAGTTTTTCGG) contained a BamHI site.
his fragment was inserted into pSLIAgDs and pSLIATPs
lasmids that had been digested with NheI and BamHI.
lasmids were expressed in COS-7 cells, and superna-
ants were assayed for secreted HN protein by a sand-
ich enzyme-linked immunosorbent assay (ELISA) using
olyclonal mouse antiserum against HN to coat the
late. Only proteins expressed with the TPA signal se-
uence were detected, and a positive plasmid was cho-
en and designated pSLIAtHN.
All plasmids were amplified in transformed Esche-
ichia coli (DH5a strain) and purified using anion ex-
hange resins (Qiagen, Chatsworth, CA). After the con-
entrations were determined, the plasmids were stored
t 220°C. The A260/280 ratios were typically 1.8 or
igher.
ransfection of cells
COS-7 cells were transfected using Lipofectamine
GIBCO BRL) according to the manufacturer’s instruc-
ions. Five hours after transfection, fresh DMEM contain-
ng 10% FBS was added. Two days later, 50 mCi/ml
35S]methionine (Amersham, Oakville, Ontario, Canada)
as added to the cells, which were incubated for another
–5 h. The transfected cells were harvested, and the
adiolabeled proteins were precipitated (van Drunen Lit-
el-van den Hurk et al., 1984) with serum specific for
HV-1 gD, BPIV3 HN, or A. pleuropneumoniae OmlA,
ollowed by protein A–Sepharose (Pharmacia). The ra-
iolabeled proteins were separated on 8.5% SDS–poly-
crylamide gels and visualized by autoradiography.
mmunizations and challenge
C57BL/6 mice were given plasmid by IM injection in
he quadriceps muscle (50 ml/leg) or ID injection in the
ail (20 ml). They were bled before inoculation and at
egular intervals to assess antibody responses, and at
he end of the experiment, spleens were collected for
ellular assays. Cotton rats were anesthetized by halo-
hane (MTC Pharmaceuticals, Cambridge, Ontario, Can-
da)/nitrous oxide (1:2) inhalation before inoculation and
lood collection procedures. They were given plasmid byM injection in the quadriceps muscle (50 ml/leg) or by ID
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44 VAN DRUNEN LITTEL-VAN DEN HURK ET AL.njection in the back (20 ml). Blood samples were ob-
ained by cardiac puncture with the animals under an-
sthesia before inoculation and at regular intervals af-
erward. The cotton rats were challenged IN by admin-
stering 0.1 ml of BPIV3 virus suspension containing 107
FU to the nares. Previously, we established that maxi-
al virus shedding occurred on days 1–2 postchallenge,
hereas an anamnestic response was expected to be
pparent on days 6–7 postchallenge (Breker-Klassen et
l., 1995).Therefore, on day 2 postchallenge, half of each
f the groups of animals was sacrificed with an overdose
f halothane/nitrous oxide. On day 6, the other half of the
nimals was sacrificed. Spleens were collected for cel-
ular assays, and lungs and trachea were collected to be
rocessed for virus and immunoglobulin recovery.
reparation of trachea and lung extracts
After euthanasia, the trachea and lungs from each rat
ere aseptically removed, weighed, homogenized in 1
l of MEM (Polytron homogenizer; Brinkmann Industries,
exdale, Ontario, Canada), and centrifuged to remove
ebris. The resulting supernatants were assayed for the
resence of BPIV3 and antibodies.
LISAs
Antibody titers (total or IgG subclass) were determined
y ELISAs as described previously (Breker-Klassen et al.,
995; Braun et al., 1997). Briefly, Immulon II microtiter
lates (Dynatech Laboratories Inc., Chantilly, VA) were
oated with sonicated, 30% to 60% sucrose-gradient pu-
ified BPIV3 in carbonate buffer at a concentration of 0.5
g/well, and incubated with serum samples serially di-
uted in 0.1 M PBS containing 0.5% Tween 20. Biotinyl-
ted goat IgG specific for mouse or cotton rat IgG
Zymed; Dimension Laboratories Inc., Mississauga, On-
ario, Canada) was used as secondary antibody. For
ouse IgG subtyping, biotinylated goat IgG specific for
ouse IgG1, IgG2a, or IgG2b (Cedarlane, Hornby, Ontario,
anada) was used. Biotinylated secondary antibodies
pecific for rat IgG (Zymed) or IgA (a gift from M. Baca-
strada) were used for rat Ig isotyping. Reactions were
isualized with streptavidin-alkaline phosphatase conju-
ate and SIGMA FAST tablets, consisting of the insoluble
ubstrates 5-bromo-4-chloro-3-indolyl phosphate (BCIP)
nd nitroblue tetrazolium (NBT) (Sigma Chemical Co., St.
ouis, MO).
irus titration
Virus obtained from tissue culture or lung and tracheal
xtracts was titrated by plaque assays. Virus was diluted
n serum-free MEM, plated on confluent Vero cells, and
llowed to adsorb at 37°C for 90 min. The cells were
ashed once with serum-free MEM and overlaid with
erum-free MEM containing 0.5% (wt/vol) agarose and 5
g of trypsin per ml. When the overlay solidified, an additional layer of serum-free MEM containing 5 mg of
rypsin/ml was added. The plaques were visualized after
days of incubation at 37°C by staining with 0.01%
wt/vol) of neutral red.
irus neutralization assay
Doubling dilutions of sera were mixed with 100 PFU of
PIV3 and incubated for 90 min at 37°C. The virus-serum
ixture was plated on confluent Vero cells and allowed
o adsorb for 90 min at 37°C. The cells were then over-
aid with agarose as described for the plaque assay. The
iter was expressed as the reciprocal of the dilution of
erum that caused a 50% reduction in plaques relative to
he virus control.
roliferation assays
Spleen cells were isolated as described previously
Baca-Estrada et al., 1996) and suspended in culture
edium consisting of RPMI 1640 (Sigma) supplemented
ith 10% FBS, 100 U/ml of penicillin (GIBCO BRL),
EPES, b-mercaptoethanol, sodium pyruvate, and non-
ssential amino acids. Splenocytes were dispensed at
3 106 cells/ml of culture medium. Subsequently, 100-ml
olumes were dispensed into the wells of microtiter
lates, and BPIV3 at 5 3 105 PFU/ml was added in a
00-ml volume to triplicate wells. After 2 days in culture,
he cells were pulsed with [methyl-3H]thymidine (Amer-
ham). The cells were harvested 18 h later, and thymi-
ine uptake was measured by scintillation counting. Pro-
iferative responses were calculated as the mean values
f triplicate wells and expressed as stimulation index (SI;
ounts/min in the presence of antigen divided by counts/
in in the absence of antigen).
LISPOT assays
Antigen-specific cytokine ELISPOT assays were car-
ied out as described previously (Baca-Estrada et al.,
996). Splenocytes were cultured for 24 h in the pres-
nce or absence of 5 3 104 PFU of BPIV3, washed twice,
nd resuspended to the appropriate concentration in
ulture medium. Nitrocellulose plates (Millipore, Bedford,
A) were coated for 2 h at room temperature with mu-
ine IFNg-specific IgG (R4–6A2) or IL-4-specific IgG
11B11) (PharMingen, Mississauga, Ontario, Canada).
plenocytes were added at a concentration of 1 3 106 or
3 105 cells in 100 ml/well. Biotinylated antibody specific
or murine IFNg (XMG1–2) and IL-4 (BVD6–24G2)
PharMingen), followed by streptavidin alkaline phospha-
ase conjugate and BCIP/NBT substrate, were used to
isualize bound cytokines.
Antigen-specific B cell ELISPOT assays were carried
ut as described previously (Papp et al., 1997; Braun et
l., 1997). Briefly, splenocytes were plated onto nitrocel-
ulose plates (Millipore) coated with either bovine serum
lbumin or pure BPIV3 at 10 mg/well in carbonate buffer.
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45DNA IMMUNIZATION WITH BPIV3 GENESiotinylated secondary antibodies specific for rat IgG
Zymed) or IgA (a gift from M. Baca-Estrada) and strepta-
idin conjugate followed by BCIP/NBT substrate were
sed to visualize antibody-secreting cells.
tatistical analyses
Data were entered into a database in the statistical
nalysis program Instat (GraphPAD Software, San Diego,
A). Differences between the means of experimental
roups were analyzed using an independent, two-tailed t
est at the level of P , 0.05.
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